Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
Back in September, all of 23andMe’s independent directors also resigned from its board — in a rare move that followed ...
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
Me restructures, cutting 40% of its workforce and ending its therapeutic programs to save $35 million annually while ...
On Tuesday, Wojcicki announced the new additions to 23andMe’s board: Andre Fernandez, a former CFO at WeWork, Inc., and NCR ...
In addition to workforce reductions, 23andMe has also decided to discontinue its therapeutic ... The situation worsened in ...